Daiichi Sankyo Co. Ltd.
Company Snapshot
Founded: 2005
Entity Type: Public
Employees: 20,171
Region: Japan
Revenue: $14,107.6 Millions
Revenue Year: 2025
Headquarter: Japan
Key Geographics: North America, Europe, Japan, Other Regions
Corporate Address: 3-5-1, Nihonbashi-honcho Chuo-ku, Tokyo 103-8426 Japan 81-3-6225-1111 www.daiichisankyo.com
Company Overview
Daiichi Sankyo Co. Ltd. is a global pharmaceutical company formed in 2005 through the merger of two established Japanese drugmakers. It researches, develops, manufactures, markets, and sells a range of pharmaceutical products, including prescription medicines, over-the-counter (OTC) products, vaccines, veterinary medicines, and medical equipment. Its portfolio covers treatments for cardiovascular diseases, oncology (cancer), metabolic conditions, infectious diseases, neurological disorders, and more.
Financial Highlights (FY 2025)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
Daiichi Sankyo Co. Ltd. In News
Company's Business Segments
- Pharmaceutical Operation : Under this segment, the company provides Oncology, Cardiovascular, Other Pharmaceuticals, and Vaccines.
Applications/End User Industries
- Healthcare
- Pharmaceuticals
- Life Sciences